Skip to main content

Peer Review reports

From: 2-deoxy-d-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial

Original Submission
13 Dec 2021 Submitted Original manuscript
17 Dec 2021 Author responded Author comments - Anant Narayan Bhatt
Resubmission - Version 2
17 Dec 2021 Submitted Manuscript version 2
20 Mar 2022 Reviewed Reviewer Report
22 Apr 2022 Reviewed Reviewer Report
4 Jun 2022 Author responded Author comments - Anant Narayan Bhatt
Resubmission - Version 3
4 Jun 2022 Submitted Manuscript version 3
15 Jul 2022 Author responded Author comments - Anant Narayan Bhatt
Resubmission - Version 4
15 Jul 2022 Submitted Manuscript version 4
Publishing
24 Jul 2022 Editorially accepted
4 Aug 2022 Article published 10.1186/s12879-022-07642-6

You can find further information about peer review here.

Back to article page